Shandong Pharmaceutical Glass Co Ltd Cash Flow Quality Index
Shandong Pharmaceutical Glass Co Ltd cash flow quality index. Shandong Pharmaceutical Glass Co Ltd (600529) has a Cash Flow Quality Index of 0.28x as of December 2025. Operating cash flow of CN¥41.46 Million is below net income of CN¥147.17 Million, suggesting accrual-heavy earnings not yet converted to cash. See 600529 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Shandong Pharmaceutical Glass Co Ltd (2001–2025)
Cash flow quality index of Shandong Pharmaceutical Glass Co Ltd from 2001 to 2025. Historical Cash Flow Quality Index for Shandong Pharmaceutical Glass Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Shandong Pharmaceutical Glass Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Shandong Pharmaceutical Glass Co Ltd Cash Flow Quality Index by Year (2001–2025)
Shandong Pharmaceutical Glass Co Ltd cash flow quality index by year from 2001 to 2025. Year-by-year earnings quality comparison for Shandong Pharmaceutical Glass Co Ltd. For the full cash flow conversion analysis, see 600529 cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.84x | CN¥576.92 Million | CN¥689.63 Million | ▼ -32.3% |
| 2024 | 1.24x | CN¥1.17 Billion | CN¥942.99 Million | ▼ -8.5% |
| 2023 | 1.35x | CN¥1.05 Billion | CN¥775.80 Million | ▲ +230.9% |
| 2022 | 0.41x | CN¥252.44 Million | CN¥618.29 Million | ▼ -67.8% |
| 2021 | 1.27x | CN¥750.44 Million | CN¥591.09 Million | ▲ +26.6% |
| 2020 | 1.00x | CN¥566.01 Million | CN¥564.44 Million | ▼ -23.2% |
| 2019 | 1.31x | CN¥599.05 Million | CN¥458.69 Million | ▲ +0.4% |
| 2018 | 1.30x | CN¥465.77 Million | CN¥358.21 Million | ▼ -17.1% |
| 2017 | 1.57x | CN¥411.96 Million | CN¥262.76 Million | ▼ -41.5% |
| 2016 | 2.68x | CN¥506.53 Million | CN¥189.05 Million | ▼ -0.5% |
| 2015 | 2.69x | CN¥389.63 Million | CN¥144.67 Million | ▲ +24.9% |
| 2014 | 2.16x | CN¥266.63 Million | CN¥123.64 Million | ▼ -1.8% |
| 2013 | 2.20x | CN¥268.60 Million | CN¥122.33 Million | ▲ +822.5% |
| 2012 | 0.24x | CN¥28.52 Million | CN¥119.83 Million | ▼ -88.5% |
| 2011 | 2.07x | CN¥274.63 Million | CN¥132.51 Million | ▲ +64.2% |
| 2010 | 1.26x | CN¥217.01 Million | CN¥171.97 Million | ▼ -26.7% |
| 2009 | 1.72x | CN¥249.27 Million | CN¥144.84 Million | ▲ +166.5% |
| 2008 | 0.65x | CN¥91.76 Million | CN¥142.06 Million | ▼ -41.3% |
| 2007 | 1.10x | CN¥122.63 Million | CN¥111.53 Million | ▲ +32.0% |
| 2006 | 0.83x | CN¥78.47 Million | CN¥94.18 Million | ▲ +56.5% |
| 2005 | 0.53x | CN¥44.09 Million | CN¥82.79 Million | ▲ +1193.8% |
| 2004 | -0.05x | CN¥-3.70 Million | CN¥75.98 Million | ▼ -105.8% |
| 2003 | 0.84x | CN¥59.35 Million | CN¥70.71 Million | ▼ -55.7% |
| 2002 | 1.89x | CN¥109.26 Million | CN¥57.72 Million | ▲ +172.6% |
| 2001 | 0.69x | CN¥28.60 Million | CN¥41.20 Million | — |